Low plasma BDNF is associated with suicidal behavior in major depression

Area of Science:

• Neuroscience
• Psychiatry
• Biochemistry

Background:

• Brain-derived neurotrophic factor (BDNF) is crucial for neuronal survival and function.
• BDNF is implicated in the pathophysiology of anxiety and depression.
• The role of BDNF in suicidal behavior remains under-investigated.

Purpose of the Study:

• To investigate plasma BDNF levels in individuals with major depressive disorder (MDD) who have attempted suicide.
• To compare BDNF levels between suicidal MDD patients, non-suicidal MDD patients, and healthy controls.
• To explore the correlation between BDNF levels and suicide attempt lethality and depression severity.

Main Methods:

• Plasma BDNF levels were quantified using enzyme-linked immunosorbent assay (ELISA).
• Participants included 32 suicidal MDD patients, 32 non-suicidal MDD patients, and 30 normal controls.
• Suicide attempt lethality was assessed using the Risk-Rescue Rating (RRR) and Lethality Suicide Attempt Rating Scale (LSARS).
• Depression severity was measured using the Hamilton Depression Rating Scale (HDRS).

Main Results:

• Plasma BDNF levels were significantly lower in suicidal MDD patients compared to non-suicidal MDD patients and normal controls (p=0.002).
• A BDNF cut-off level of 444.58 pg/ml differentiated suicidal from non-suicidal depression with notable sensitivity and specificity.
• No significant correlation was found between BDNF levels and suicide attempt lethality (LSARS, RRR) or between fatal and non-fatal attempts.
• BDNF levels did not differ between non-suicidal depressed patients and normal controls (p=0.996).

Conclusions:

• Reduced plasma BDNF levels are associated with suicidal behavior in patients with major depression.
• Plasma BDNF may serve as a potential biological marker for identifying suicidal depression.
• Further research is warranted to elucidate the precise mechanisms linking BDNF to suicidal ideation and behavior.